Why Partner With Itamar? Itamar is a world leader in proven companion diagnostic solutions for the pharmaceutical industry.
For further information about Itamar’s companion diagnostic development programs contact us |
Proven Leadership Itamar is the world leader in endothelial function companion diagnostics. Regulatory Experience Pharmacovigilance regulatory requirements for optimal protection of patients in clinical trials have added an extra layer to drug development. Itamar has proven experience working with drug companies and regulatory bodies—including the U.S. Food and Drug Administration—to develop companion diagnostics and gain regulatory approval. Itamar works with the drug company and regulatory authorities to ensure the test is approved as a companion diagnostic to support the sales of the new drug. Technology Itamar’s EndoPAT technology can be used in multiple platform settings. Independence Itamar is an independent company that works with many pharmaceutical companies on their companion diagnostic projects. Itamar ensures strict confidentiality with all of its partners. Cost Savings And Shortened Development Time By using EndoPAT testing as a surrogate marker for drug “success,” this eliminates useless latter-stage testing on patients who will not benefit and use only those who will. This also allows pharma to bring the data on “failed” patients back into the preclinical development cycle to find a treatment that will work. |
